Examkin

Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A physician evaluates a 2828-year-old woman during her first prenatal visit at 88 weeks of gestation. She has a medical history of primary hypothyroidism due to Hashimoto thyroiditis and has been well-controlled on a stable daily dose of 100 \mug100 \text{ \mu g} of levothyroxine for the past two years. She reports mild fatigue but denies palpitations, heat intolerance, or vaginal bleeding. Her vital signs are within normal limits. Physical examination is unremarkable, with a normal-sized thyroid gland and no palpable nodules. Laboratory studies obtained today reveal a thyroid-stimulating hormone (TSH) level of 4.8 mIU/L4.8 \text{ mIU/L} (reference range for the first trimester: 0.10.1 to 2.5 mIU/L2.5 \text{ mIU/L}) and a free thyroxine (T4) level at the lower limit of normal. Which of the following is the most appropriate next step in the management of this patient's thyroid disease?

  1. A
    Maintain the current levothyroxine dose and recheck serum TSH at 1616 weeks of gestation
  2. B
    Order a serum thyroid peroxidase antibody level before making any medication adjustments
  3. Increase the levothyroxine dose by approximately 30%30\% and recheck serum TSH in 44 weeksCevap
  4. D
    Maintain the current levothyroxine dose and add oral liothyronine therapy
  5. E
    Order an MRI of the pituitary gland to rule out a secondary cause of thyroid dysfunction

Cevap

Increase the levothyroxine dose by approximately 30% and recheck serum TSH in 4 weeks.
The correct answer addresses the physiological changes of early pregnancy. Increased circulating estrogen stimulates the hepatic synthesis of thyroxine-binding globulin (TBG). This excess TBG binds free T4, transiently lowering active hormone levels and triggering an increase in TSH. In a healthy individual, the thyroid gland responds by increasing T4 production. However, a patient with Hashimoto thyroiditis cannot mount this endogenous response. Consequently, as soon as pregnancy is confirmed, the exogenous levothyroxine dose should be preemptively increased by approximately 30% (often achieved by advising the patient to take two additional doses per week). The TSH must then be rechecked in 4 weeks to ensure it falls within the trimester-specific target range (typically 0.1 to 2.5 mIU/L for the first trimester) to prevent adverse outcomes such as spontaneous abortion, preterm birth, and impaired fetal neurocognitive development.

Adım Adım Çözüm

1
Identify the patient's condition and physiological state.
The patient is a pregnant female at 8 weeks gestation with a history of Hashimoto thyroiditis, currently taking levothyroxine.
Pregnancy significantly alters thyroid hormone pharmacokinetics and physiological requirements.
2
Interpret the laboratory results within the correct clinical context.
The TSH of 4.8 mIU/L is elevated above the strict first-trimester target of less than 2.5 mIU/L.
Pregnancy-specific reference ranges must be used to ensure adequate maternal T4 delivery to the fetus.
3
Determine the physiological mechanism driving the lab abnormality.
Increased maternal estrogen stimulates thyroxine-binding globulin (TBG) production, which binds more free T4 and increases the overall thyroid hormone demand.
Understanding the mechanism explains why the patient's baseline dose is suddenly inadequate.
4
Select the appropriate management step.
The exogenous levothyroxine dose must be empirically increased by approximately 30% with a TSH re-evaluation in 4 weeks.
Because the patient's diseased thyroid gland cannot autonomously increase production to meet pregnancy demands, the clinician must proactively increase the synthetic hormone dose to prevent fetal complications.

Anahtar Kavram

Due to increased thyroxine-binding globulin (TBG) and the metabolic demands of pregnancy, patients with preexisting primary hypothyroidism require an immediate dose increase in their levothyroxine (typically by 30%) as soon as pregnancy is confirmed, followed by serial TSH monitoring.
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru